| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.096 | 0.04 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.08 | 0.09 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.035 | 0.4 |